Up a level |
Reinmuth, Niels and Bryl, Maciej and Bondarenko, Igor and Syrigos, Kostas and Vladimirov, Vladimir and Zereu, Manuela and Bair, Angel H. and Hilton, Fiona and Liau, Katherine and Kasahara, Kazuo (2019) PF‑06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First‑Line Treatment for Advanced Non‑Squamous Non‑Small‑Cell Lung Cancer: A Randomized, Double‑Blind Study. BioDrugs. pp. 1-16. ISSN 1173-8804 (Print) 1179-190X (Online)